Answers are grounded in this paper and cite their sources.
Tricyclic antidepressants present with diverse central nervous system, anticholinergic, and myocardial symptoms requiring clinical vigilance.
CNS is the main site of therapeutic action of TCAs and these have direct effects on the CNS. The TCAs antidepressant effect is recognized to be the blockade of monoamine reuptake, at both noradrenergic and serotonergic nerve endings. Tricyclic compounds have anticholinergic effects and predominantly action on myocardium sodium channels then this group has a various symptoms; Since TCA has various presentation; we must ready to find different signs and symptoms of that. We must know all of sign and symptoms to be ready for manage it or them because cannot predict what patients will manifest.
No takes yet. Share an insight, caveat, or question.
Habibollahi et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: